These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 19470052

  • 1. Efficacy and safety of long-term mycophenolate sodium therapy in pemphigus vulgaris.
    Baskan EB, Yilmaz M, Tunali S, Saricaoglu H.
    J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1432-4. PubMed ID: 19470052
    [Abstract] [Full Text] [Related]

  • 2. Mycophenolate mofetil and enteric-coated mycophenolate sodium in the treatment of pemphigus vulgaris and pemphigus foliaceus.
    Doukaki S, Platamone A, Alaimo R, Bongiorno MR.
    J Dermatolog Treat; 2015 Feb; 26(1):67-72. PubMed ID: 24521072
    [Abstract] [Full Text] [Related]

  • 3. Successful treatment with mycophenolate mofetil of four Japanese patients with pemphigus vulgaris.
    Koga H, Ishii N, Hamada T, Karashima T, Nakama T, Yasumoto S, Hashimoto T.
    Eur J Dermatol; 2010 Feb; 20(4):472-5. PubMed ID: 20406724
    [Abstract] [Full Text] [Related]

  • 4. [Open trial of mycophenolate mofetil in the treatment of resistant pemphigus vulgaris].
    Chams-Davatchi C, Nonahal Azar R, Daneshpazooh M, Valikhani M, Hallaji Z, Barzegari M, Firouz AR, Zakeri M.
    Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):23-5. PubMed ID: 11937925
    [Abstract] [Full Text] [Related]

  • 5. Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent.
    Megahed M, Schmiedeberg S, Becker J, Ruzicka T.
    J Am Acad Dermatol; 2001 Aug; 45(2):256-9. PubMed ID: 11464188
    [Abstract] [Full Text] [Related]

  • 6. Treatment of pemphigus vulgaris with mycophenolate mofetil as a steroid-sparing agent.
    Esmaili N, Chams-Davatchi C, Valikhani M, Farshidfar F, Parvaneh N, Tamizifar B.
    Eur J Dermatol; 2008 Aug; 18(2):159-64. PubMed ID: 18424375
    [Abstract] [Full Text] [Related]

  • 7. An evaluation of the usefulness of mycophenolate mofetil in pemphigus.
    Powell AM, Albert S, Al Fares S, Harman KE, Setterfield J, Bhogal B, Black MM.
    Br J Dermatol; 2003 Jul; 149(1):138-45. PubMed ID: 12890207
    [Abstract] [Full Text] [Related]

  • 8. Enteric-coated mycophenolate sodium as a steroid-sparing agent in pemphigus treatment: a retrospective study.
    De Simone C, Caldarola G, Perino F, Venier A, Guerriero G.
    Dermatol Ther; 2012 Jul; 25(2):219-22. PubMed ID: 22741942
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic evaluation of mycophenolate mofetil for pemphigus.
    Doukaki S, Pistone G, Aricò M, Bongiorno MR.
    Expert Opin Drug Metab Toxicol; 2011 Feb; 7(2):237-44. PubMed ID: 21192770
    [Abstract] [Full Text] [Related]

  • 11. Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil.
    Mimouni D, Anhalt GJ, Cummins DL, Kouba DJ, Thorne JE, Nousari HC.
    Arch Dermatol; 2003 Jun; 139(6):739-42. PubMed ID: 12810504
    [Abstract] [Full Text] [Related]

  • 12. Improved protocol for treatment of pemphigus vulgaris with protein A immunoadsorption.
    Shimanovich I, Herzog S, Schmidt E, Opitz A, Klinker E, Bröcker EB, Goebeler M, Zillikens D.
    Clin Exp Dermatol; 2006 Nov; 31(6):768-74. PubMed ID: 16824051
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of enteric-coated mycophenolate sodium in patients with active lupus nephritis.
    Mak SK, Lo KY, Lo MW, Chan SF, Tong GM, Wong PN, Wong AK.
    Nephrology (Carlton); 2008 Jun; 13(4):331-6. PubMed ID: 18476916
    [Abstract] [Full Text] [Related]

  • 14. Pulsed intravenous cyclophosphamide and methylprednisolone therapy in refractory pemphigus.
    Saha M, Powell AM, Bhogal B, Black MM, Groves RW.
    Br J Dermatol; 2010 Apr; 162(4):790-7. PubMed ID: 19922532
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate is effective in the treatment of pemphigus vulgaris.
    Enk AH, Knop J.
    Arch Dermatol; 1999 Jan; 135(1):54-6. PubMed ID: 9923781
    [Abstract] [Full Text] [Related]

  • 16. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus.
    Beissert S, Werfel T, Frieling U, Böhm M, Sticherling M, Stadler R, Zillikens D, Rzany B, Hunzelmann N, Meurer M, Gollnick H, Ruzicka T, Pillekamp H, Junghans V, Luger TA.
    Arch Dermatol; 2006 Nov; 142(11):1447-54. PubMed ID: 17116835
    [Abstract] [Full Text] [Related]

  • 17. Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil.
    Biot Sdel R, Franco JP, Lima RB, Pereira HN, Marques LP, Martins CJ.
    An Bras Dermatol; 2014 Nov; 89(6):980-4. PubMed ID: 25387507
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of mycophenolate mofetil as a steroid-sparing agent in pemphigus: a randomized, prospective study.
    Ioannides D, Apalla Z, Lazaridou E, Rigopoulos D.
    J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):855-60. PubMed ID: 21752101
    [Abstract] [Full Text] [Related]

  • 19. Mycophenolate mofetil as an adjuvant therapy for classic and endemic pemphigus foliaceus.
    Kawashita MY, Tsai K, Aoki V, Santi CG, Maruta CW, Rivitti E.
    J Dermatol; 2005 Jul; 32(7):574-80. PubMed ID: 16335874
    [Abstract] [Full Text] [Related]

  • 20. A case with Listeria meningitis during administration of mycophenolate mofetil for pemphigus vulgaris.
    Akyol M, Ozçelik S, Engin A, Ozel l ahin G.
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1447-8. PubMed ID: 17958877
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.